Oriola Oyj (HEL:ORIOLA)
Finland · Delayed Price · Currency is EUR | Market Cap | 166.19M -25.2% |
| Revenue (ttm) | 1.91B +96.8% |
| Net Income | -19.50M |
| EPS | -0.11 |
| Shares Out | 184.25M |
| PE Ratio | n/a |
| Forward PE | 10.40 |
| Dividend | 0.03 (3.33%) |
| Ex-Dividend Date | Mar 26, 2026 |
| Volume | 77,600 |
| Open | 0.9010 |
| Previous Close | 0.9000 |
| Day's Range | 0.8920 - 0.9020 |
| 52-Week Range | 0.8660 - 1.2600 |
| Beta | 0.48 |
| Analysts | Buy |
| Price Target | 0.99 (+9.76%) |
| Earnings Date | Oct 29, 2026 |
About Oriola Oyj
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, ... [Read more]
Financial Performance
In 2025, Oriola Oyj's revenue was 1.91 billion, an increase of 13.41% compared to the previous year's 1.68 billion. Losses were -27.20 million, 35.3% more than in 2024.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for ORIOLA stock is "Buy." The 12-month stock price target is €0.99, which is an increase of 9.76% from the latest price.
News
Oriola Oyj Earnings Call Transcript: Q2 2026
Net sales grew 1.7% in Q2, with profitability stable despite higher freight costs. Product segment saw 11% growth, while service segment declined due to weaker Swedish distribution and advisory. Adjusted EBITDA is expected to rise for the year, supported by cost discipline and market growth.
Oriola Oyj Quarterly report: Q2 2026
Oriola Oyj has published its Q2 2026 quarterly earnings report on July 17, 2026.
Oriola Oyj Slides: Q2 2026
Oriola Oyj has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 17, 2026.
Oriola Oyj Transcript: CMD 2026
Management outlined a strategy to double adjusted EBITDA by 2029 through organic growth, investments in automation and digitalization, and efficiency gains. Key initiatives include major supply chain upgrades, a focus on high-margin segments, and profitability improvements at Kronans Apotek.
Oriola Oyj Press release: FY 2026
Oriola Oyj issued a press release on May 12, 2026, disclosing material business information to investors.
Oriola Oyj Slides: FY 2026
Oriola Oyj has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 12, 2026.
Oriola Oyj Earnings Call Transcript: Q1 2026
Net sales grew 10.7% year-over-year to EUR 49.8 million, with adjusted EBITDA at EUR 7.7 million and a 15.4% margin. Investments in automation and new distribution centers progressed, while the joint venture underperformed, prompting corrective actions.
Oriola Oyj Quarterly report: Q1 2026
Oriola Oyj has published its Q1 2026 quarterly earnings report on April 29, 2026.
Oriola Oyj Slides: Q1 2026
Oriola Oyj has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Oriola Oyj Annual Shareholders Meeting Transcript
Oriola Oyj Annual Shareholders Meeting Transcript
Oriola Oyj Earnings Call Transcript: Q4 2025
Net sales rose 14% and Adjusted EBITDA reached EUR 35.1 million, driven by strong growth in both distribution and wholesale segments, despite a negative net profit due to ERP and JV-related costs. Cash flow and liquidity improved, and a new automated distribution center was announced.
Oriola Oyj Annual report: Q4 2025
Oriola Oyj has published its Q4 2025 annual report on February 25, 2026.
Oriola Oyj Quarterly report: Q4 2025
Oriola Oyj has published its Q4 2025 quarterly earnings report on February 25, 2026.
Oriola Oyj Slides: Q4 2025
Oriola Oyj has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 25, 2026.
Oriola Oyj Earnings Call Transcript: Q3 2025
Net sales rose 9% year-over-year to EUR 463 million, with Adjusted EBITDA improving to EUR 9.6 million, driven by both distribution and wholesale segments. The ERP project and impairments weighed on reported EBITDA and net profit, but outlook for EBITDA growth remains unchanged.
Oriola Oyj Quarterly report: Q3 2025
Oriola Oyj has published its Q3 2025 quarterly earnings report on October 30, 2025.
Oriola Oyj Slides: Q3 2025
Oriola Oyj has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 30, 2025.